# Efficacy and Tolerability Study of Device, RD047-26 for the Treatment of Mild to Moderate Atopic Dermatitis in Adults

> **NCT01232985** · PHASE2 · COMPLETED · sponsor: **Oculus Innovative Sciences, Inc.** · enrollment: 17 (actual)

## Conditions studied

- Atopic Dermatitis
- Pruritus

## Interventions

- **DEVICE:** RD047-26

## Key facts

- **NCT ID:** NCT01232985
- **Lead sponsor:** Oculus Innovative Sciences, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2012-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01232985

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01232985, "Efficacy and Tolerability Study of Device, RD047-26 for the Treatment of Mild to Moderate Atopic Dermatitis in Adults". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01232985. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*